The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Mia Woodward, MD: The Role of Telehealth in Ophthalmology
Mia Woodward, MD, discusses the future of telehealth in ophthalmology and the biggest issues that need to be corrected going forward.
Cluster, Genetic Trends Observed in Autoimmune Diseases
An assessment of the world's largest twin registry found telling patterns of common autoimmune diseases including type 1 diabetes.
Study Examines Cardiovascular Effects of GLP-1 Agonists
No significant differences in cardiovascular outcomes among patients receiving different GLP-1 agonists including exenatide extended-release, exenatide immediate-release, liraglutide, albiglutide, and dulaglutide.
CPAP May Aid in Patient Weight Loss
Over the course of 16 weeks, OSA patients receiving CPAP treatment lost 5.7 pounds more on average than patients not receving CPAP therapy.
Adam DeVore, MD: Confidently Treating HF with Sacubitril/Valsartan
How the PIONEER-HF and PARADIGM-HF trials have focused on varied, but realistic heart failure patients.
Cardiologists Far More Likely to See Diabetic Patient than Endocrinologists
A year-long outpatient care study showed that patients with type 2 diabetes and comorbid cardiovascular disease are 5 times as likely to visit a cardiologist.
Hispanic Patients with T2DM Benefit from Adjunct SGLT-2 Therapy
A new Puerto Rico-based trial shows that patients on add-on SGLT-2 inhibitors reported greater HbA1C reductions.
Wouter Jukema, MD, PhD: PCSK9 Inhibitor Potential, Tolerability
It's been 4 years since the drug class reached the market. Are patients adhering to the therapy, and what more potential does it have?
Michael J. Reardon, MD: Long-Term TAVR Plans
What researchers from the low-risk TAVR trial anticipate they will find in their decade-long assessment.
Steven Nissen, MD: Balancing Therapy & Lifestyle in Guidelines
With cardiovascular drug classes inhibitors owning discussion, how will recent or upcoming guideline updates address their use alongside lifestyle management?
Rajan Patel, MD: Breaking New Ground in Minimally Invasive CV Care
Progress in invasive measures for cardiovascular conditions has allowed clinicians the ability to venture into new ground.
Khaldoun Tarakji, MD, MPH: Assessing, Advancing the WRAP-IT Results
What plans are held to progress the impressive findings of an envelope for cardiovascular device infection?
Adam DeVore, MD: Sacubitril/Valsartan Benefits in PIONEER-HF Extension
An extension of the study showed sacubitril/valsartan's benefit as an initial hospitalized heart failure therapy.
E-Cigarette Use Linked to Increased Stroke, Coronary Artery Disease
Observed data from a 96,000-plus participant survey found the popularized cigarette alternative is also associated with a greater risk of depression.
Wouter Jukema, MD, PhD: ODYSSEY OUTCOMES in Post-Acute Coronary Syndrome
How alirocumab fared for patients with polyvascular disease in a subset of the major clinical trial.
Malissa J. Wood, MD: Improving Women's Cardiovascular Diagnoses and Care
Heart disease is the greatest cause of death in women, and Wood believes female patients would better from a multidisciplinary approach.
Empagliflozin Reduces Heart Failure Re-Hospitalization, Mortality
Among participants of the EMPA-REG OUTCOME trial who experienced heart failure, empagliflozin was associated with lower rates of short-term re-hospitalization and death.
Khaldoun Tarakji, MD, MPH: WRAP-IT Results
How an antibiotic envelope can address concerns of infection in cardiovascular devices.
Remote Blood Pressure Monitoring Linked to Improved Patient Control
A new study of a blood pressure-monitoring mobile app reports patients with diabetes could reach better thresholds.
Michael J. Reardon, MD: The TAVR Study for Low-Risk Mortality
What do some of the findings from one of the biggest presentations at ACC mean for the state of valve replacement care?
Douglas Drachman, MD: Learning Through Cardiovascular Crises
Why every care provider must be able to prepare for and commit to an "emergency protocol" in the face of adversity.
Study: Pregnant Women Rarely Screened for Hyperlipidemia
A 5000-plus patient study found that about 80% of young women have never been administered a lipid test.
Young Adult Heart Attacks on the Rise in the US
The rate of heart attacks among patients under 40 years old has been increasing by 2% annually for the past decade.
ACC, AHA Present New Cardiovascular Prevention Guideline
New recommendations for prevention focus on risk factors, new therapies, and press against the popular use of aspirin as a preventive therapy.
Diabetes Amputation Risk Not Worsened by SGLT-2 Inhibitors
A 3 million-plus patient longitudinal study found the drug class was no worse for amputation risks than other diabetes therapies, despite recent conflicting studies.
Steve Nissen, MD: The Next Generation of SGLT-2 Trials
Now that SGLT-2 inhibitors have reached the market, how will clinicians compare their benefits in patients?
Jason H. Wasfy, MD: Optimal Inpatient, Outpatient Heart Care
How is telehealth already influencing how some hospitals manage cardiovascular concerns?
Midwest Hospital Infective Endocarditis Rates Spiked During Opioid Crisis
Admissions for infective endocarditis related to intravenous drug use increased 436% from 2012-2017 at an Ohio medical center.
Jose Tafur, MD: Managing Patient Goals Through Stent Therapy
How advancing stent therapy options have come to bridge the gap between improving and elongating a patient's life.
Steve Nissen, MD: SGLT-2 Inhibitors, Then & Now
How the effective cardiovascular drug class have reach a state of impending head-to-head trials.